ClinicalTrials.govpublic full text
L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients
chronic kidney disease, l-arginine, blood pressure, adma, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 863293
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.